Table 2. Dietary intake and physical activity levels of 68 type 2 diabetic patients.
Variable | Lignan treatment | Placebo treatment | ||
Week 0 | Week 12 | Week 0 | Week 12 | |
Energy (kcal/day) | 1911±329 | 1858±365 | 1840±327 | 1866±321 |
Fat (% of energy) | 32±6 | 31±7 | 31±6 | 31±6 |
SFA (g/d) | 10±4 | 10±4 | 10±3 | 10±3 |
MUFA (g/d) | 14±5 | 14±6 | 14±5 | 14±6 |
PUFA (g/d) | 22±9 | 20±9 | 21±9 | 21±9 |
Protein (% of energy) | 17±3 | 18±3 | 17±3 | 17±3 |
Carbohydrate (% of energy) | 51±6 | 52±7 | 52±6 | 51±6 |
Total fiber (g/d) | 10±4 | 10±3 | 10±4 | 9±4 |
Dietary cholesterol (mg/d) | 394±153 | 439±206 | 403±195 | 410±171 |
Physical activity level(MET-hours/week) | 88.0±32.7 | 92.3±37.7 | 89.4±32.4 | 87.6±35.4 |
Data are mean±Standard Deviation. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; MET, metabolic equivalent value.